Magnetic Resonance Magnetic Resonance Spectroscopy Spectroscopy (MRS) (MRS) Basic Principles Basic Principles Single Voxel Techniques Single Voxel Techniques Chemical Shift Imaging (CSI) Chemical Shift Imaging (CSI) Water Suppression Water Suppression Clinical Applications Clinical Applications
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Magnetic ResonanceMagnetic ResonanceSpectroscopySpectroscopy
Chemical Shift Imaging (CSI)Chemical Shift Imaging (CSI)Water SuppressionWater Suppression
Clinical ApplicationsClinical Applications
MR SpectroscopyMR Spectroscopy• Magnetic Resonance Spectroscopy (MRS) Magnetic Resonance Spectroscopy (MRS)
provides a non-invasive method of studying provides a non-invasive method of studying metabolism in vivo. metabolism in vivo.
• The tissue’s chemical environment The tissue’s chemical environment determines the frequency of a “metabolite determines the frequency of a “metabolite peak” in an MRS “spectrum”.peak” in an MRS “spectrum”.
2
3
Spectrum: graph of amount of Spectrum: graph of amount of metabolites versus frequencymetabolites versus frequency
NAA Peak
Choline Peak
Creatine Peak
MR SpectroscopyMR Spectroscopy• Candidates for MRS include:Candidates for MRS include:
• 11H, H, 3131P, P, 1313C, C, 2323Na, Na, 77Li, Li, 1919F, F, 1414N, N, 1515N, N, 1717O, O, 3939KK
• The most commonly studied nuclei are The most commonly studied nuclei are 11H H and and 3131PP
• This lecture is focused on Proton (This lecture is focused on Proton (11H) H) SpectroscopySpectroscopy
• Electrons have HUGE magnetic momentsElectrons have HUGE magnetic moments– ~700 times the proton magnetic moment~700 times the proton magnetic moment
• The static magnetic BThe static magnetic B00 field “seen” by a nucleus field “seen” by a nucleus in a molecule is shielded by the covalent electron in a molecule is shielded by the covalent electron structure surrounding the nucleus. structure surrounding the nucleus.
• The electron cloud produces a small change in The electron cloud produces a small change in the magnetic field around nuclei in molecules.the magnetic field around nuclei in molecules.
6
Proton SpectroscopyProton Spectroscopy
• Electrons in water molecules (HElectrons in water molecules (H22O) create a O) create a different local magnetic field than electrons in fat different local magnetic field than electrons in fat molecules (CHmolecules (CH22))
• This is “Chemical Shift” which we see in clinical This is “Chemical Shift” which we see in clinical images.images.
Proton SpectroscopyProton Spectroscopy• Chemical shiftsChemical shifts in in HzHz are are dependentdependent on on
the strength of the applied field Bthe strength of the applied field B00 – Chemical shift between water and fat:Chemical shift between water and fat:
• 220 Hz at 1.5T220 Hz at 1.5T
• 440 Hz at 3T440 Hz at 3T
• Chemical shiftsChemical shifts in in ppmppm are are independentindependent of the strength of the applied field Bof the strength of the applied field B00
– Chemical shift between water and fat:Chemical shift between water and fat:• 3.44 ppm at 1.5T3.44 ppm at 1.5T
Chemical shift imaging (Chemical shift imaging (CSICSI).).•2D-CSI2D-CSI•3D-CSI3D-CSI
Essential: suppress the water signal, CHEmical-Shift-Essential: suppress the water signal, CHEmical-Shift-Selective (Selective (CHESSCHESS) pulses) pulses
Proton SpectroscopyProton Spectroscopy
12
•The concentration of pure water is 55.6 M for The concentration of pure water is 55.6 M for HH22O or 111 M for O or 111 M for 11H.H.•The water concentration in the brain is about The water concentration in the brain is about 70% or 36 M. 70% or 36 M. •In vivo In vivo 11H spectroscopy requires water H spectroscopy requires water suppression because the 36 M water signal suppression because the 36 M water signal overpowers the 1-10 mM signal of the overpowers the 1-10 mM signal of the metabolites.metabolites.
Proton SpectroscopyProton Spectroscopy
13
This figure demonstrates the importance of suppressing the This figure demonstrates the importance of suppressing the water signal. The metabolites of interest have a signal water signal. The metabolites of interest have a signal one hundred times smaller than that of the water peak, one hundred times smaller than that of the water peak, and without water suppression would be poorly resolvedand without water suppression would be poorly resolved
Proton Spectroscopy (SVS with PRESS)Proton Spectroscopy (SVS with PRESS)
Basic diagram of SVS with spin echo (ref #1)Basic diagram of SVS with spin echo (ref #1)• Water-suppressionWater-suppression• The 90° pulse excites a slice. The 90° pulse excites a slice. • The first 180° pulse refocuses the transverse The first 180° pulse refocuses the transverse
magnetization in a row of tissue within the magnetization in a row of tissue within the slice. slice.
• The second 180° pulse refocuses the The second 180° pulse refocuses the magnetization within a column of the row, magnetization within a column of the row, leaving a single voxel. leaving a single voxel.
• Then, the signal represents a combination of Then, the signal represents a combination of spins in that voxel precessing at slightly spins in that voxel precessing at slightly different frequencies (function of time).different frequencies (function of time).
• Fourier transform of signal Fourier transform of signal number of number of spins at a given frequency in a voxel spins at a given frequency in a voxel (function of frequency).(function of frequency).
For one acquisition scheme– Point RESolved Spectroscopy For one acquisition scheme– Point RESolved Spectroscopy (PRESS)(PRESS)
Proton Spectroscopy Proton Spectroscopy (SVS with PRESS)(SVS with PRESS)
The effect of echo time in SE single voxel spectroscopy (SVS).The effect of echo time in SE single voxel spectroscopy (SVS).
Left: TE=30ms; Right: TE=144 ms. Glx (glutamine) and myoinositol (mI) have Left: TE=30ms; Right: TE=144 ms. Glx (glutamine) and myoinositol (mI) have short Tshort T22 values and are not visible on long TE spectra. values and are not visible on long TE spectra.
Proton Spectroscopy Proton Spectroscopy (SVS with PRESS)(SVS with PRESS)
16
Major healthy brain metabolite peaks:Major healthy brain metabolite peaks:
short TE spectra (add’l peaks): 4) myoinositol (mI) at 3.56 ppm, 5) glutamine short TE spectra (add’l peaks): 4) myoinositol (mI) at 3.56 ppm, 5) glutamine and glutamate (Glx) between 2.05-2.5 ppm and 3.65-3.8 ppm, and 6) and glutamate (Glx) between 2.05-2.5 ppm and 3.65-3.8 ppm, and 6) glucose at 3.43 ppm.glucose at 3.43 ppm.
long TE spectra: 1) N-acetylaspartate (NAA) at 2.02 ppm, 2) choline (Cho) at long TE spectra: 1) N-acetylaspartate (NAA) at 2.02 ppm, 2) choline (Cho) at 3.20 ppm, and 3) creatine (Cr) at 3.02 ppm and 3.9 ppm. 3.20 ppm, and 3) creatine (Cr) at 3.02 ppm and 3.9 ppm.
Proton Spectroscopy Proton Spectroscopy (SVS with STEAM)(SVS with STEAM)
Basic diagram of SVS with STEAM: Basic diagram of SVS with STEAM:
•Water-suppressionWater-suppression•The 90° pulse excites a slice. The 90° pulse excites a slice. •A second 90° pulse refocuses the transverse A second 90° pulse refocuses the transverse magnetization in a row of tissue within the magnetization in a row of tissue within the slice. slice.
•A third 90° pulse refocuses the magnetization A third 90° pulse refocuses the magnetization within a column of the row, leaving a single within a column of the row, leaving a single voxel.voxel.
Negative to STEAM: rephasing only about Negative to STEAM: rephasing only about 50% of the original generated transverse 50% of the original generated transverse magnetization (low SNR). magnetization (low SNR). ~ (sort of ) Positive to STEAM: shorter echo ~ (sort of ) Positive to STEAM: shorter echo times than PRESS sequence.times than PRESS sequence.
Phase encoding gradients can be utilized, as in Phase encoding gradients can be utilized, as in imaging, in order to encode spatial information.imaging, in order to encode spatial information.
Figure 4 illustrates a simple 2D chemical shift Figure 4 illustrates a simple 2D chemical shift imaging (CSI) acquisition scheme. imaging (CSI) acquisition scheme.
Figure 5 illustrates the imaging setup for a 2D CSI Figure 5 illustrates the imaging setup for a 2D CSI acquisition. acquisition.
A single slice is defined through the area of interest, A single slice is defined through the area of interest, and then a box is specified within this (white lines). and then a box is specified within this (white lines).
Spectra will then be generated for all voxels within the Spectra will then be generated for all voxels within the box. box.
20
Figure 5Figure 5
21
This figure presents the spectra for a low grade brainstem glioma. This figure presents the spectra for a low grade brainstem glioma. SE CSI acquisition: two spectra (TE=30 ms--second column, and SE CSI acquisition: two spectra (TE=30 ms--second column, and 144 ms--third column). The first column shows the voxel 144 ms--third column). The first column shows the voxel corresponding to the spectra on the same row. Rows: 1st=lesion corresponding to the spectra on the same row. Rows: 1st=lesion spectra, 2nd= normal brain spectra.spectra, 2nd= normal brain spectra.
The lesion spectra demonstrate decreased The lesion spectra demonstrate decreased NAANAA (a marker of (a marker of neuronal integrity) and increased neuronal integrity) and increased cholinecholine (a marker of myelin (a marker of myelin breakdown). The short TE spectrum demonstrates elevated breakdown). The short TE spectrum demonstrates elevated myo-myo-inositolinositol (a marker of glial cells). (a marker of glial cells).
Figure 6 (next slide) presents a color-coded choline metabolite Figure 6 (next slide) presents a color-coded choline metabolite map.map.
• The clinical utility of the brain spectrum rests The clinical utility of the brain spectrum rests upon 2 important properties:upon 2 important properties:– The nature and concentration of brain chemicals The nature and concentration of brain chemicals
identified is remarkably constant—identified is remarkably constant—• A “normal” brain spectrum is readily recognizedA “normal” brain spectrum is readily recognized
– The particular neurochemicals concerned are of The particular neurochemicals concerned are of clinical relevance in healthy and diseased brain.clinical relevance in healthy and diseased brain.
Single Voxel Spectra from PhantomSingle Voxel Spectra from PhantomOn Left: STEAM 35 TE On Right: PRESS 35 TEOn Left: STEAM 35 TE On Right: PRESS 35 TE
28
Single Voxel Spectra PRESS TE 144Single Voxel Spectra PRESS TE 144
29
Single Voxel Spectra PRESS TE 288Single Voxel Spectra PRESS TE 288
Brain SpectroscopyBrain Spectroscopy
• Voxel placementVoxel placement30
• SpectrumSpectrum
Brain SpectroscopyBrain Spectroscopy
• Voxel placementVoxel placement• With saturation bandsWith saturation bands
31
• Spectrum from GBMSpectrum from GBM• Elevated choline, lactateElevated choline, lactate
• decreased NAAdecreased NAA
32
2D CSI of phantom --processed result2D CSI of phantom --processed result
Mutlivoxel spectroscopyMutlivoxel spectroscopy
33
3D CSI from 3D CSI from phantom—phantom—processed result processed result with composite with composite metabolite mapmetabolite map
Spectroscopy of the ProstateSpectroscopy of the Prostate
• Prostate cancer is associated with Prostate cancer is associated with proportionately proportionately lowerlower levels oflevels of citratecitrate and and higher levels of choline and creatine than higher levels of choline and creatine than are seen in benign prostatic hyperplasia are seen in benign prostatic hyperplasia (BPH) or in normal prostate tissue.(BPH) or in normal prostate tissue.
34
35
Spectroscopy of the ProstateSpectroscopy of the Prostate
Spectroscopy of the ProstateSpectroscopy of the Prostate
greatly reduced citrategreatly reduced citrate, elevated choline , elevated choline prostate cancer prostate cancer
37
The diagnostic value of MR The diagnostic value of MR spectroscopy is typically based on the spectroscopy is typically based on the detection of elevated levels of choline detection of elevated levels of choline compounds, which are a marker of compounds, which are a marker of active tumors.active tumors.
Spectroscopy of the BreastSpectroscopy of the Breast
(From previous slide) (From previous slide) Palpable mammographically detected and Palpable mammographically detected and biopsy-proved invasive lobular carcinoma biopsy-proved invasive lobular carcinoma in left breast of 56-year-old woman. in left breast of 56-year-old woman. This is a true-positive finding. This is a true-positive finding.
Spectroscopy of the BreastSpectroscopy of the Breast
Suspicious nonmass lesion detected at Suspicious nonmass lesion detected at screening MR imaging in 38-year-old screening MR imaging in 38-year-old woman withwoman withBRCA-1 BRCA-1 gene who was imaged at day 11 of gene who was imaged at day 11 of her menstrual cycle. her menstrual cycle. This is a true-negative finding.This is a true-negative finding.
Spectroscopy of the BreastSpectroscopy of the Breast
elevatedelevated levels of levels of cholinecholine compounds compounds marker marker of active tumors.of active tumors.
Spectroscopy of the BreastSpectroscopy of the Breast
43
Spectroscopy at 3T vs 1.5TSpectroscopy at 3T vs 1.5T
1.5T1.5T3T3T
44
References:References:
• Proton magnetic resonance spectroscopy in Proton magnetic resonance spectroscopy in the brain: Report of AAPM MR Task group the brain: Report of AAPM MR Task group #9.#9. Drost, D.J., et al., Med Phys 29(9) Drost, D.J., et al., Med Phys 29(9) Sept 2002.Sept 2002.
• Questions and Answers in Magnetic Questions and Answers in Magnetic Resonance ImagingResonance Imaging (2 (2ndnd Edition). Elster, Edition). Elster, A.D. and Burdette, J. H. Mosby, St. Louis A.D. and Burdette, J. H. Mosby, St. Louis 20012001
45
References:References:
• Medical Magnetic Resonance Imaging and Medical Magnetic Resonance Imaging and Spectroscopy.Spectroscopy. Edited by Budinger Edited by Budinger &Margulis. Society of Magnetic &Margulis. Society of Magnetic Resonance in Medicine 1986Resonance in Medicine 1986
• Clinical Applications of MR SpectroscopyClinical Applications of MR Spectroscopy
Edited by Mukherji Wiley & Sons, New Edited by Mukherji Wiley & Sons, New York 1998York 1998
46
References:References:
• MRI from Picture to ProtonMRI from Picture to Proton D.W. D.W. McRobbie et al. Cambridge University McRobbie et al. Cambridge University Press 2003Press 2003
• Magnetic Resonance Spectroscopy of Magnetic Resonance Spectroscopy of Neurological DiseasesNeurological Diseases E. R. Danielsen E. R. Danielsen Marcel Dekker, Inc. New York 1998.Marcel Dekker, Inc. New York 1998.
Carroll, et. al., Carroll, et. al., Magnetic Resonance Magnetic Resonance Imaging and Imaging and Spectroscopy of Prostate CancerSpectroscopy of Prostate Cancer;; REVIEWS IN REVIEWS IN UROLOGY UROLOGY Vol. 8 Suppl. 1 2006Vol. 8 Suppl. 1 2006
Bartella, et al., Bartella, et al., Enhancing Nonmass Lesions in the Breast: Enhancing Nonmass Lesions in the Breast: Evaluation with Proton (1H) MR SpectroscopyEvaluation with Proton (1H) MR Spectroscopy Radiology Radiology Volume 245 (1) October 2007Volume 245 (1) October 2007